Skip to main content
  1. Home
  2. Emerging Tech
  3. Virtual Reality
  4. News

This $75 camera drone fits in the palm of your hand, comes with a set of first-person view goggles

Add as a preferred source on Google

Want to learn to fly drones without the fear of crashing a $1,000 UAV on your maiden flight? If so, you may be interested in Aerix’s new Vidius VR, a.k.a. the world’s smallest virtual reality drone — which not only measures a scant 4.3cm x 4.3cm x 2.5cm, but has an equally tiny price tag to match.

Now available for pre-order at the special price of just $75, Vidius VR is capable of flying up to 100 feet away and performing 360 degree flips and rolls, all while streaming and recording live video, which you can check out using the (included) AERIX VR Goggles.

Recommended Videos

“With the headset on, you get a first-person view as if you were inside the drone’s tiny little cockpit,” Robert Morrison, the owner/founder of Aerix Drones — as well as its chief engineer — tells Digital Trends. “It’s amazingly fun to be able to have that experience of flying something that’s so small, but yet to be able to see it on a screen that’s directly in front of your face.”

Morrison says that Vidius VR builds on all the feedback he received for the Vidius drone launched at the start of 2016. It includes some impressive adds-on not usually found in smaller drones at a comparable price point. These include an in-built barometer “Altitude Assistance Module,” which helps pilots maintain a steady altitude so they can focus on steering instead. In addition, there’s the ability to fly in “Headless Mode,” a pre-programmed Tricks Mode, and more.

Ultimately, however, the real selling point of Vidius VR is the fact that it provides a miniature drone you can fly safely within the confines of your own home. “You can fly them in your house, you can fly them in your office, you can fly them in your college dorm, and you don’t have to worry about breaking the drone or breaking anything else,” Morrison says. “They’re small enough that they’re not going to cause any damage.”

All that plus a VR headset as well? Consider us sold.

Luke Dormehl
I'm a UK-based tech writer covering Cool Tech at Digital Trends. I've also written for Fast Company, Wired, the Guardian…
Students who use AI every day may be falling behind, while moderate users pull ahead
New global testing data suggests more AI in the classroom isn't automatically better.
Logo, Text

I assumed more AI access might help students learn faster. However, a new OECD study dispels that misconception for me and everyone else who gave their children a paid version of AI chatbots, thinking it would help them through their educational journey. 

According to PISA 2025 data from 760,000 students in 91 countries, students who use AI daily score meaningfully worse on standardized tests than their peers. The full picture is more complicated than a simple ban would fix.

Read more
XPENG just put its humanoid robot on the production line, and it walked itself out
IRON clocks in for its first shift
XPENG Iron

XPENG’s humanoid robot has officially joined the workforce, and it even got an employee badge. The Chinese automaker announced on September 8 that its next-generation IRON had completed assembly and autonomously walked off its newly commissioned humanoid robot production line in Guangzhou.

CEO He Xiaopeng then pinned a staff badge onto the robot, symbolically welcoming it to the XPENG team. It is a charming little ceremony for a machine that the company hopes will eventually become a regular part of everyday life. XPENG is moving IRON beyond R&D prototypes toward production-line manufacturing, applying the quality-control systems and manufacturing experience it has developed through its electric vehicle business.

Read more
An AI-designed drug might help slow aging, but we’re not there yet
The results hint at a possible anti-aging effect, but there’s still a long way to go before we know what it means.
medical test tubes

Rentosertib, a drug Insilico Medicine designed almost entirely using AI, was created to treat idiopathic pulmonary fibrosis, a disease that scars and stiffens the lungs over time. But fighting lung disease was only half the plan from the start.

According to a new study published in Nature Biotechnology, the drug's target was chosen specifically because it overlaps heavily with the biology of aging, and the whole trial was designed to test whether treating the lungs could also mean turning back the body's biological clock.

Read more